Literature DB >> 31326470

Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi.

Margriet W J Hokken1, B J Zwaan2, W J G Melchers3, P E Verweij3.   

Abstract

Opportunistic fungal pathogens can cause a diverse range of diseases in humans. The increasing rate of fungal infections caused by strains that are resistant to commonly used antifungals results in difficulty to treat diseases, with accompanying high mortality rates. Existing and newly emerging molecular resistance mechanisms rapidly spread in fungal populations and need to be monitored. Fungi exhibit a diversity of mechanisms to maintain physiological resilience and create genetic variation; processes which eventually lead to the selection and spread of resistant fungal pathogens. To prevent and anticipate this dispersion, the role of evolutionary factors that drive fungal adaptation should be investigated. In this review, we provide an overview of resistance mechanisms against commonly used antifungal compounds in the clinic and for which fungal resistance has been reported. Furthermore, we aim to summarize and elucidate potent generators of genetic variability across the fungal kingdom that aid adaptation to stressful environments. This knowledge can lead to recognizing potential niches that facilitate fast resistance development and can provide leads for new management strategies to battle the emerging resistant populations in the clinic and the environment.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adaptation; Antifungal compounds; Antifungal resistance mechanisms; Aspergillus spp.; Candida spp.; Cryptococcus spp.; Mutation rate; Reproduction

Mesh:

Substances:

Year:  2019        PMID: 31326470     DOI: 10.1016/j.fgb.2019.103254

Source DB:  PubMed          Journal:  Fungal Genet Biol        ISSN: 1087-1845            Impact factor:   3.495


  14 in total

1.  Antifungals, arthropods and antifungal resistance prevention: lessons from ecological interactions.

Authors:  Steve Kett; Ayush Pathak; Stefano Turillazzi; Duccio Cavalieri; Massimiliano Marvasi
Journal:  Proc Biol Sci       Date:  2021-02-03       Impact factor: 5.349

2.  Tulbaghia violacea (Harv) Exerts its Antifungal Activity by Reducing Ergosterol Production in Aspergillus flavus.

Authors:  Benesh M Somai; Vuyokazi Belewa; Carminita Frost
Journal:  Curr Microbiol       Date:  2021-06-08       Impact factor: 2.188

Review 3.  Post-Translational Modifications of PCNA: Guiding for the Best DNA Damage Tolerance Choice.

Authors:  Gemma Bellí; Neus Colomina; Laia Castells-Roca; Neus P Lorite
Journal:  J Fungi (Basel)       Date:  2022-06-10

Review 4.  Mechanisms of triazole resistance in Aspergillus fumigatus.

Authors:  Ashley V Nywening; Jeffrey M Rybak; Phillip David Rogers; Jarrod R Fortwendel
Journal:  Environ Microbiol       Date:  2020-10-21       Impact factor: 5.491

5.  Investigation of Alternative Therapeutic and Biocidal Options to Combat Antifungal-Resistant Zoonotic Fungal Pathogens Isolated from Companion Animals.

Authors:  Elaine Meade; Micheal Savage; Mark Slattery; Mary Garvey
Journal:  Infect Dis Rep       Date:  2021-04-11

6.  Phenomic profiling of a novel sibling species within the Scedosporium complex in Thailand.

Authors:  T Kitisin; S Ampawong; W Muangkaew; P Sukphopetch
Journal:  BMC Microbiol       Date:  2021-02-09       Impact factor: 3.605

Review 7.  Insects, Rodents, and Pets as Reservoirs, Vectors, and Sentinels of Antimicrobial Resistance.

Authors:  Willis Gwenzi; Nhamo Chaukura; Norah Muisa-Zikali; Charles Teta; Tendai Musvuugwa; Piotr Rzymski; Akebe Luther King Abia
Journal:  Antibiotics (Basel)       Date:  2021-01-12

8.  Oceanapiside, a Marine Natural Product, Targets the Sphingolipid Pathway of Fluconazole-Resistant Candida glabrata.

Authors:  Doralyn S Dalisay; Evan W Rogers; Tadeusz F Molinski
Journal:  Mar Drugs       Date:  2021-02-26       Impact factor: 5.118

9.  Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity.

Authors:  Vanessa Duncan; Daniel Smith; Laura Simpson; Emma Lovie; Laura Katvars; Leon Berge; Jennifer Robertson; Shane Smith; Carol Munro; Derry Mercer; Deborah O'Neil
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

10.  New Data on the In Vitro Activity of Fenticonazole against Fluconazole-Resistant Candida Species.

Authors:  Margherita Cacaci; Giulia Menchinelli; Riccardo Torelli; Dominique Sanglard; Maurizio Sanguinetti; Brunella Posteraro
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.